Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 3, 2009, Pages 193-198

  Wakino, Shu ^a   Imai, Eiko ^a   Yoshioka, Kyoko ^a   Kamayachi, Tadashi ^a   Minakuchi, Hitoshi ^a   Hayashi, Koichi ^a   Inamoto, Hajime ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Fatality; Hemodialysis; Multi drug esistance; Nosocomial pneumonia; Quinolone; Stenotrophomonas maltophilia

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANDIDA ALBICANS; CONFERENCE PAPER; FATALITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SPUTUM CULTURE; SPUTUM EXAMINATION; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS MALTOPHILIA; UNIVERSITY HOSPITAL;

AGED; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PNEUMONIA, BACTERIAL; RENAL DIALYSIS; STENOTROPHOMONAS MALTOPHILIA;

EID: 66549100677     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00693.x     Document Type: Conference Paper

References (15)

1. Slinin Y, Foley RN, Collins AJ. Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int 2006 70 : 1135 41.
2. Vanholder R, Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 1993 3 : 1541 54.
3. Irifune K, Ishida T, Shimoguchi K et al. Pneumonia caused by Stenotrophomonas maltophilia with a mucoid phenotype. J Clin Microbiol 1994 32 : 2856 7.
4. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966 45 : 493 6.
5. Kobayashi Y, Kizaki M, Kawakami Y, Uchida H, Ikeda Y. Assessment of oxacillin salt agar for detection of MRSA identified by presence of the mecA gene. J Hosp Infect 1993 23 : 279 85.
6. Nicodemo AC, Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007 26 : 229 37.
7. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001 32 : S104 13.
8. Micozzi A, Venditti M, Monaco M et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000 31 : 705 11.
9. Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 2007 109 : 2615 22.
10. Nicodemo AC, Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007 26 : 229 37.
11. Fujita J, Yamadori I, Xu G et al. Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir Med 1996 90 : 35 8.
12. Cheng AF, Li MK, Ling TK, French GL. Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy. J Antimicrob Chemother 1987 20 : 283 5.
13. Neu HC, Saha G, Chin NX. Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors. Diagn Microbiol Infect Dis 1989 12 : 283 5.
14. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998 11 : 57 80. (Pubitemid 28046016)
15. Pankuch GA, Jacobs MR, Appelbaum PC. Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin. Antimicrob Agents Chemother 1994 38 : 369 70.